Related Experiment Video
Updated: Aug 9, 2026

A Bilingual Computational Workflow for Identifying Potential PLK1 Inhibitors in American Sign Language and English
Published on: April 3, 2026
[Effects of PLK1 gene silence on apoptosis of K562 cells]
Min Zhang1, Zhi-chao Chen, Fang Liu
1Institute of Hematology, Union Hospital, Tongji Medical College, Huazhong University of Science & Technology, Wuhan 430022, China.
Objective:
To investigate the effects of PLK1 gene silence by short hairpin RNA (shRNA) on PLK1 expression and apoptosis in K562 cells, and explore the role of PLK1 in the pathogenesis of leukemia.
Methods:
The shRNA fragment targeting at 1416-1436 bp of PLK1 mRNA was synthesized and cloned into pEGFP-H1 vector, named as pEGFP-H1/PLK1. The empty control, pEGFP-H1 and pEGFP-H1/PLK1 were transfected into K562 cells respectively via electroporation. 24 h or 48 h after transfection, gene and protein expression of PLK1 in the cells were assayed by RT-PCR and Western blot analysis respectively, cells viability by MTT assay, caspase-3 activity by colorimetry, cell cycle and apoptosis by FACS.
Results:
24 and 48 h after transfection, PLK1 expression in K562 cells was 1.25 +/- 0.07 for control group, 0.52 +/- 0.04 and 0.25 +/- 0.02 for pEGFP-H1/PLK1 group, and 1.24 +/- 0.08 and 1.23 +/- 0.09 for pEGFP-H1 group respectively. The alteration status of PLK1 protein levels were similar to that of PLK mRNA levels. The apoptosis rate was (8.3 +/- 0.6)% in control group, (8.7 +/- 0.7)% in pEGFP-H1 group and (49.7 +/- 3.8)% and (82.3 +/- 6.9)% in pEGFP-H1/PKLK1 group at 24 and 48 h, respectively. In addition, cell fraction at G(2)/M phase was increased obviously compared with control and pEGFP-H1-transfected group.
Conclusion:
The constructed shRNA can remarkably inhibit PLK1 expression and transfected K562 cell proliferation, increase apoptosis and block cell-cycle, suggesting that PLK1 play important roles in apoptosis and cell-cycle control of leukemia cells.
Insights
Short hairpin RNA (shRNA) targeting PLK1 gene significantly inhibited PLK1 expression in K562 leukemia cells. This suppression led to reduced cell proliferation, increased apoptosis, and cell cycle arrest, highlighting PLK1
Area of Science:
- Molecular Biology
- Cancer Research
- Genetics
Background:
- Polo-like kinase 1 (PLK1) is a key regulator of cell division.
- Dysregulation of PLK1 is implicated in the pathogenesis of various cancers, including leukemia.
Purpose of the Study:
- To investigate the effects of PLK1 gene silencing using short hairpin RNA (shRNA) on PLK1 expression and apoptosis in K562 leukemia cells.
- To explore the role of PLK1 in the pathogenesis of leukemia.
Main Methods:
- Synthesized and cloned shRNA targeting PLK1 mRNA into pEGFP-H1 vector.
- Transfected K562 cells with the constructed vector (pEGFP-H1/PLK1) or empty vector via electroporation.
- Assayed PLK1 expression, cell viability, caspase-3 activity, cell cycle, and apoptosis at 24 and 48 hours post-transfection.
Main Results:
- shRNA significantly inhibited PLK1 mRNA and protein expression in K562 cells.
- Apoptosis rate increased significantly in cells transfected with pEGFP-H1/PLK1 compared to control groups.
- Cell cycle analysis revealed an increased fraction of cells in the G2/M phase.
Conclusions:
- Constructed shRNA effectively inhibits PLK1 expression in K562 cells.
- PLK1 plays a critical role in regulating apoptosis and cell cycle progression in leukemia cells.
- Targeting PLK1 may represent a potential therapeutic strategy for leukemia.
Related Concept Videos
The Intrinsic Apoptotic Pathway
Abnormal Proliferation
Inhibition of Cdk Activity
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
DNA Damage Can Stall the Cell Cycle
DNA Damage can Stall the Cell Cycle
